首頁 > 市場調查報告書 > 醫療設備

眼科設備

市場調查報告書

商品編碼

1858992

眼科器材市場機會、成長促進因素、產業趨勢分析及預測（2025-2034年）

Ophthalmic Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年10月13日 | 出版商:

Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球眼科設備市場價值為 487 億美元，預計到 2034 年將以 4.2% 的複合年成長率成長至 727 億美元。

市場成長的驅動力來自於對微創治療需求的不斷成長、眼部疾病盛行率的上升以及人口老化的加劇。技術進步顯著提升了診斷和手術方法，提高了診斷的準確性和患者的治療效果。人工智慧驅動的成像平台、雷射手術和光學相干斷層掃描等先進系統能夠更快地檢測並更有效地治療視力問題。智慧隱形眼鏡和穿戴式視力輔助設備的日益普及進一步提升了患者的便利性和治療效果。隨著診斷、影像和手術設備的不斷進步，眼科護理變得更加精準、經濟高效且易於獲取。全球對視力健康的日益重視以及常規眼科檢查的增加，正在擴大客戶群。生活方式的改變、螢幕使用時間的增加以及更長的數位互動導致視力障礙顯著增加，促使更多人尋求視力保健解決方案。這些因素，加上數位科技在醫療保健領域的日益整合，必將推動未來幾年市場的發展。

市場範圍
起始年份	2024
預測年份	2025-2034
起始值	487億美元
預測值	727億美元
複合年成長率	4.2%

2024年，視力保健產品市佔率達51.9%。其中，隱形眼鏡和眼鏡片等子類別的需求持續強勁，這主要得益於長時間接觸電子螢幕的使用者對視力問題的日益關注。使用者傾向於選擇具有光線調節、防眩光和藍光過濾等附加功能的專業鏡片，以提高螢幕使用和戶外活動時的舒適度。眼鏡片尤其受到近視和遠視等屈光不正患者的青睞，他們希望找到既能矯正視力又能滿足時尚需求的個人化解決方案。

到2024年，消費者市場將佔據47.8%的佔有率，這主要得益於年輕人對視力矯正工具使用量的增加。隨著人們對螢幕的依賴性日益增強，尤其是在年輕人和上班族群體中，時尚、高效且易於購買的眼鏡需求明顯增加。用戶積極尋求便利的選擇，例如訂閱式鏡片配送、虛擬試戴和線上配鏡，所有這些都促進了市場擴張。這一趨勢正在重塑消費者的購買體驗，並促使製造商在功能和時尚之間進行創新。

2024年，北美眼科器材市場佔36.8%的佔有率。該地區的領先地位得益於其強大的醫療保健基礎設施、日益增強的眼睛健康意識以及對新技術的積極接受。人口老化導致青光眼、白內障和視網膜疾病等眼科疾病風險增加，也推動了對先進眼科治療的需求。醫療保險的普及和優惠的報銷政策提高了手術和診斷程序的可及性，進一步提升了該地區的市場滲透率。

眼科器材市場的主要參與者包括愛爾康 (Alcon)、博士倫 (Bausch+Lomb)、庫博光學 (CooperVision)、強生 (Johnson & Johnson)、尼德克 (NIDEK)、豪雅 (HOYA)、拓普康醫療 (TOPCON Healthcare)、海涅 (HEINE)、歐菲泰克 (Ophtec)、JJISS GISS」、EJISS GISS GISS GJISS GISS GJV (Ophtec (COBURN TECHNOLOGIES)、佳能 (Canon)、依視路 (Essilor)、齊默眼科 (Ziemer OPHTHALMOLOGY) 和維信尼克斯 (VISIONIX)。全球眼科器材市場的企業正致力於產品創新、拓展全球業務並提升客戶互動。他們大力投資研發，力求將整合人工智慧、智慧穿戴裝置和增強成像功能的下一代設備推向市場。與診所、醫院和零售網路建立策略合作夥伴關係有助於擴大其分銷網路。各公司也透過數位化平台強調個人化解決方案，提供遠距眼科檢查、電子處方和虛擬試戴工具。為了滿足價格敏感型市場的需求，許多公司正在拓展產品組合，提供兼具成本效益和先進性的產品選擇。

產業生態系分析
產業影響因素
- 成長促進因素
  - 眼科疾病患者人數增加
  - 產品技術進步
  - 有利的政府舉措
  - 人們對微創手術的需求和偏好日益成長
  - 隱形眼鏡和眼鏡的普及率不斷上升
- 產業陷阱與挑戰
  - 眼科設備價格昂貴
  - 翻新眼科設備的使用率不斷提高
- 機會
  - 高階人工水晶體和超音波乳化設備的使用日益普及。
  - 新興市場的擴張
成長潛力分析
監管環境
- 北美洲
- 歐洲
- 亞太地區
技術與創新格局
- 當前技術趨勢
- 新興技術
消費者行為趨勢
2024年各地區定價分析
永續性和環境影響
- 使用可回收材料
- 節能型製造程序
投資環境
波特的分析
PESTEL 分析
未來市場趨勢
價值鏈分析

第4章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
- 全球的
- 北美洲
- 歐洲
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀錶板
關鍵進展
- 併購
- 合作夥伴關係與合作
- 新產品發布
- 擴張計劃

第5章：市場估算與預測：依產品分類，2021-2034年

主要趨勢
視力保健產品
- 隱形眼鏡
  - 軟性隱形眼鏡
  - 硬式透氣性隱形眼鏡（RGP）
  - 托里卡
  - 其他隱形眼鏡
- 眼鏡鏡片
外科器械
- 白內障手術器械
  - 人工水晶體
  - 超音波乳化裝置
  - 眼科黏彈性裝置
  - 白內障手術雷射
  - IOL注射器
  - 其他白內障手術器械
- 青光眼手術器械
  - 青光眼引流裝置
  - 青光眼雷射
  - 微創青光眼手術（MIGS）
  - 其他青光眼手術設備
- 屈光手術器械
  - 準分子雷射
  - 飛秒雷射
  - 其他屈光手術器械
- 玻璃體視網膜手術器械
  - 光凝雷射
  - 照明設備
  - 玻璃體視網膜包
  - 玻璃體切除機
  - 玻璃體切除探針
  - 其他玻璃體視網膜手術器械
診斷和監測設備
眼科配件

第6章：市場估算與預測：依最終用途分類，2021-2034年

主要趨勢
消費者
醫院
專科診所
門診手術中心
其他用途

第7章：市場估計與預測：依地區分類，2021-2034年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
MEA
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第8章：公司簡介

Alcon
Bausch+Lomb
Canon
COBURN TECHNOLOGIES
CooperVision
Essilor
HAAG-STREIT GROUP
HEINE
HOYA
Johnson & Johnson
NIDEK
ophtec
TOPCON Healthcare
VISIONIX
ZEISS
ziemer OPHTHALMOLOGY

簡介目錄

Product Code: 2917

The Global Ophthalmic Devices Market was valued at USD 48.7 billion in 2024 and is estimated to grow at a CAGR of 4.2% to reach USD 72.7 billion by 2034.

Market growth is being propelled by increasing demand for minimally invasive treatments, rising prevalence of eye-related disorders, and a surge in the aging population. Technological progress has significantly advanced diagnostic and surgical methods, improving both accuracy and patient outcomes. Sophisticated systems like AI-driven imaging platforms, laser-based procedures, and optical coherence tools are enabling quicker detection and more efficient treatment of vision conditions. The increasing use of smart lenses and wearable vision aids is further improving patient convenience and outcomes. With ongoing advancements in diagnostics, imaging, and surgical equipment, eye care is becoming more precise, cost-effective, and accessible. Rising global awareness of vision health, combined with an increase in routine eye check-ups, is contributing to a larger customer base. Lifestyle shifts, increased screen exposure, and longer digital engagement have led to a notable rise in vision impairments, prompting more people to adopt vision care solutions. These factors, combined with growing integration of digital technologies in healthcare, are set to enhance the market trajectory in the years ahead.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$48.7 Billion
Forecast Value	$72.7 Billion
CAGR	4.2%

The vision care products segment held a 51.9% share in 2024. Subcategories include contact lenses and spectacle lenses, which continue to witness strong demand due to the surge in vision-related concerns among users exposed to digital screens for prolonged periods. Users are opting for specialized lenses that offer added features like light-adjusting properties, anti-glare coatings, and blue-light filtration to improve comfort during screen time and outdoor activities. Spectacle lenses are particularly in demand among people with refractive errors such as myopia and hyperopia, as they look for personalized solutions that align with both vision correction and style needs.

The consumer segment held a 47.8% share in 2024, fueled by increased usage of vision correction tools among younger individuals. As screen dependency increases, especially among the youth and working population, there's a clear shift toward stylish, effective, and easily accessible eyewear. Users are actively seeking convenient options, including subscription-based lens deliveries, virtual try-ons, and online prescriptions, all of which contribute to market expansion. This trend is reshaping the consumer buying experience and encouraging manufacturers to innovate with both function and fashion in mind.

North America Ophthalmic Devices Market held a 36.8% share in 2024. The region's dominance is reinforced by a strong healthcare infrastructure, heightened awareness around eye health, and willingness to adopt new technologies. An aging population with a higher risk of diseases such as glaucoma, cataracts, and retinal disorders also drives the need for advanced eye treatments. The availability of health insurance and favorable reimbursement structures supports greater access to surgical and diagnostic procedures, further increasing market penetration across the region.

Key players in the Ophthalmic Devices Market are Alcon, Bausch+Lomb, CooperVision, Johnson & Johnson, NIDEK, HOYA, TOPCON Healthcare, HEINE, Ophtec, HAAG-STREIT GROUP, ZEISS, COBURN TECHNOLOGIES, Canon, Essilor, Ziemer OPHTHALMOLOGY, and VISIONIX. Companies operating in the Global Ophthalmic Devices Market are focusing on product innovation, expanding their global reach, and improving customer engagement. They are investing heavily in research and development to bring next-generation devices with AI integration, smart wearables, and enhanced imaging features to market. Strategic partnerships with clinics, hospitals, and retail networks help enhance their distribution footprint. Firms are also emphasizing personalized solutions through digital platforms, offering remote eye exams, e-prescriptions, and virtual try-on tools. To cater to price-sensitive markets, many companies are diversifying their product portfolios with cost-effective yet advanced options.

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Data mining sources
- 1.3.1 Global
- 1.3.2 Regional/Country
1.4 Base estimates and calculations
- 1.4.1 Base year calculation
- 1.4.2 Key trends for market estimation
1.5 Primary research and validation
- 1.5.1 Primary sources
1.6 Forecast model
1.7 Research assumptions and limitations

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis
2.2 Key market trends
- 2.2.1 Regional trends
- 2.2.2 Product trends
- 2.2.3 End use trends
2.3 CXO perspectives: Strategic imperatives
- 2.3.1 Key decision points for industry executives
- 2.3.2 Critical success factors for market players
2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increase in number of people suffering from ophthalmic disorders
  - 3.2.1.2 Technological advancements in products
  - 3.2.1.3 Favorable government initiatives
  - 3.2.1.4 Growing demand and preference for minimally invasive surgeries
  - 3.2.1.5 Rising adoption of contact lenses and spectacles
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of the ophthalmic devices
  - 3.2.2.2 Increasing adoption of refurbished ophthalmic devices
- 3.2.3 Opportunities
  - 3.2.3.1 Growing adoption of premium IOLs and phacoemulsification devices
  - 3.2.3.2 Expansion in emerging markets
3.3 Growth potential analysis
3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
3.5 Technology and innovation landscape
- 3.5.1 Current technological trends
- 3.5.2 Emerging technologies
3.6 Consumer behavior trends
3.7 Pricing analysis, by region, 2024
3.8 Sustainability and environmental impact
- 3.8.1 Use of recyclable materials
- 3.8.2 Energy-efficient manufacturing processes
3.9 Investment landscape
3.10 Porter's analysis
3.11 PESTEL analysis
3.12 Future market trends
3.13 Value chain analysis

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
- 4.3.1 Global
- 4.3.2 North America
- 4.3.3 Europe
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
4.7 Key developments
- 4.7.1 Mergers & acquisitions
- 4.7.2 Partnerships & collaborations
- 4.7.3 New product launches
- 4.7.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

5.1 Key trends
5.2 Vision care products
- 5.2.1 Contact lenses
  - 5.2.1.1 Soft contact lenses
  - 5.2.1.2 Rigid gas permeable lenses (RGP)
  - 5.2.1.3 Toric
  - 5.2.1.4 Other contact lenses
- 5.2.2 Spectacle lenses
5.3 Surgical devices
- 5.3.1 Cataract surgery devices
  - 5.3.1.1 Intraocular lenses
  - 5.3.1.2 Phacoemulsification devices
  - 5.3.1.3 Ophthalmic viscoelastic devices
  - 5.3.1.4 Cataract surgical Lasers
  - 5.3.1.5 IOL injectors
  - 5.3.1.6 Others cataract surgery devices
- 5.3.2 Glaucoma surgery devices
  - 5.3.2.1 Glaucoma drainage devices
  - 5.3.2.2 Glaucoma lasers
  - 5.3.2.3 Minimally invasive glaucoma surgery (MIGS)
  - 5.3.2.4 Other glaucoma surgery devices
- 5.3.3 Refractive surgery devices
  - 5.3.3.1 Excimer lasers
  - 5.3.3.2 Femtosecond lasers
  - 5.3.3.3 Other refractive surgery devices
- 5.3.4 Vitreoretinal surgery devices
  - 5.3.4.1 Photocoagulation lasers
  - 5.3.4.2 Illumination devices
  - 5.3.4.3 Vitreoretinal packs
  - 5.3.4.4 Vitrectomy machines
  - 5.3.4.5 Vitrectomy probes
  - 5.3.4.6 Other Vitreoretinal surgery devices
5.4 Diagnostic and monitoring devices
5.5 Ophthalmic accessories

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

6.1 Key trends
6.2 Consumers
6.3 Hospitals
6.4 Specialty clinics
6.5 Ambulatory surgery centers
6.6 Other End uses

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
7.6 MEA
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE